Dr Sherri's statement of "Virtually No Side Effects" isn't as yet priced into the stock, IMO. The side effects of Keytruda can be agony. A few years ago neighbor who was a big guy about 6'4" & 240 lbs and part of our golf group, came down with cancer and had to have treatments every 3 weeks(@$12.9K per probably more now), would sit on his sofa for the next few days and cry, until he passed! RIP Rich. These oncologists know the agony their patients can go through after the treatments they administer. Don't think that if another treatment appears with higher efficacy that can be administered with ease in only an easy treatment or two with "VIRTUALLY NO SIDE EFFECTS", they wouldn't switch to it if for no other reason than to releave their patients agony. One has told me as much. If that is the case, when TLT's ACT becomes available IMO, the demand for 1433 could be very substantcial. Profits could be huge, not to mention the benefits it could provide cancer patients worldwide. IMO, TLT's potential is unlimited if it can avoid being swallowed up by Big Pharma.